HSCT
Clinical trials for HSCT explained in plain language.
Never miss a new study
Get alerted when new HSCT trials appear
Sign up with your email to follow new studies for HSCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a biologic calm the lungs after stem cell transplant?
Disease control Recruiting nowThis phase 2 trial tests whether tezepelumab, a biologic drug that blocks a protein called TSLP, can reduce bronchial flare-ups in people who develop bronchiolitis obliterans syndrome (BOS) after an allogeneic stem cell transplant. BOS is a chronic lung condition that causes airw…
Matched conditions: HSCT
Phase 2 • Sponsor: Hopital Foch • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New drug aims to speed platelet recovery in blood cancer transplants
Disease control Recruiting nowThis study tests a drug called romiplostim N01 in 130 blood cancer patients receiving a stem cell transplant from a half-matched donor. The drug is given weekly for up to 4 weeks to help platelets recover faster, reducing the need for transfusions and bleeding risk. Half the pati…
Matched conditions: HSCT
Phase 1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Inhaled xenon gas lights up the lungs on MRI
Diagnosis Recruiting nowResearchers are testing whether hyperpolarized xenon MRI can show how well lungs move gas between air sacs, tissue, and red blood cells. The study includes children and adults who have had or are being evaluated for a stem-cell transplant, people with rare lung diseases or gas-ex…
Matched conditions: HSCT
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC